Portal de Periódicos da CAPES

DARU Journal of Pharmaceutical Sciences; The 2012 report of Editor-in-Chief

2012; Springer Nature; Volume: 20; Issue: 1 Linguagem: Inglês

10.1186/1560-8115-20-1

2008-2231

Mohammad Abdollahi,

Health Sciences Research and Education

Adipose tissue is a primary site of obesity-induced inflammation, which has been emerging as an important contributor to obesity associated disorders.The factors influencing adipose tissue-induced inflammation and the resulting pathophysiological events remain poorly understood.However, dietary fiber consumptions appear to be protective.Short-chain fatty acids such as propionic acid (PA) are the principal products of the dietary fiber fermentation by microbiota.Therefore, we aim to investigate the influence of PA on inflammation, lipogenesis and glucose uptake markers from human subcutaneous adipose tissue (SAT).We showed that the treatment of SATwith PA resulted in a significant downregulation of inflammatory parameters (e.g.TNF-α and IP-10) and macrophage markers (e.g.CD163 and MMP-9).The expression levels of PA receptors (i.e.G protein coupled receptor-41 and -43) in human primary adipocytes were very low in comparison with SATand macrophages.Upon PA treatment, no anti-inflammatory effect was observed in human adipocytes.PA significantly upregulated the expression of lipoprotein lipase (LPL), sterol regulatory-element-binding protein-1c (SREBP-1c) and glucose transporter 4 (GLUT-4), which are associated with lipogenesis and glucose uptake.We also showed that the observed anti-inflammatory effects of PA on SATwere partly mediated by Gi/o protein coupled receptor.Our data suggests that PA anti-inflammatory effects on SATare mediated partly via Gi/o proteins, leading to the improved expression of factors associated with lipogenesis and glucose uptake.These responses appeared to be not mediated by adipocytes; but most probably by macrophages.The current study provides new knowledge, which can be used as a potential new avenue for drug development in preventing obesityrelated inflammation and metabolic disorders in future.